Nicotine Addiction Pharmacy Practice II Winter 2005.

Slides:



Advertisements
Similar presentations
NC STEP/Mission Hospitals School Cessation and Treatment Guide.
Advertisements

Nicotine Gum Nicotine absorbed mucosal membranes 2mg and 4mg strength
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Assessment and Pharmacological Treatment of Tobacco Dependence
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
Nurses’ Role with Clients/Patients Who Use Tobacco Created by the Registered Nurses’ Association of Ontario.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Key Public Health issues of smoking Passive smoking in home, car, workplace, restaurants etc. Self- induced disease and cost of smoking related diseases.
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health
Philip Tønnesen,2005 Smoking cessation Philip Tønnesen, M.D, Dr.med.sci.
Practical Smoking Cessation Allan Prochazka, M.D., M.Sc. Denver VAMC.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
SMOKING CESSATION Leading Preventable Cause of Death 400,000 to 500,000 deaths per year in USA 3 Million deaths world wide 1 of every 6 deaths in USA Directly.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
Nancy Rigotti, MD Treatment Review: Overview of the Evidence Base for Tobacco Dependence Treatment 10/09/2011.
Module 2 - Assessment, Diagnosis, and Pharmacotherapy: Integrating Tobacco Use Interventions into Chemical Dependence Services.
Quitting Smoking How to stop smoking … for good!.
Copyright Alcohol Medical Scholars Program1 The Relationships Between Alcohol Use Disorders and Nicotine Dependence Margaret Rukstalis, M.D. University.
Healthy Air for Kids Campaign
1 Smoking Cessation Presented by CIGNA Employee Assistance Program Copyright 2008 CIGNA HealthCare – Confidential & Privileged – Not for Distribution.
Smoking Cessation: the pharmacotherapeutic and non-pharmacotherapeutic approaches to addictive behavior Andrea C. McKean February 22, 2007.
Tobacco Cessation Competency Class Section 2: Assessment Tools & Types of Counseling.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
Addressing Tobacco Use within College Health Services National Conference of Tobacco or Health December 12, 2003 – Boston, MA Michael P. McNeil, M.S. Coordinator,
The Last Kiss An Internist’s Look at Smoking Cessation AIMGP 2007 Ken Locke MD, FRCPC.
Tobacco Video “Chewing Tobacco & Nicotine Addiction”Video “Chewing Tobacco & Nicotine Addiction” Length: 1:41Length: 1:41.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Prepared by: Dr. Mohammad Shaikhani University of Sulaimani College of Medicine. Dept of Medicine.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
Facilitating Behavior Change Applying Prochaska’s Transtheoretical Model Bev Schalk, R.N., M.Ed.
SMOKING CESSATION Anju Mattoo, M.D..
Smoking Cessation for Recovery 2015
BY: SHAWNA HARPER JUNE 16 TH, 2015 SMOKING CESSATION.
Using Standardized Patients to Teach Smoking Cessation Susan Stangl, MD, MSEd David Geffen School of Medicine at UCLA.
NICOTINE LOZENGE Commit (GlaxoSmithKline); generics Nicotine polacrilex formulation Delivers ~25% more nicotine than equivalent gum dose Sugar-free, mint.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
-Tobacco is the leading preventable cause of disease, disability, and death in the United States (NIDA, 2012). -About 1 in every 5 deaths in the U.S. result.
Types of help Available NHS Stop Smoking Services Nicotine Replacement Therapy (NRT) Other Pharmacological Treatments (non nicotine) Alternative Therapies.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.
Smoking cessation Supporting customers to quit. What you need to know PSA Presentation text 2 Discuss the health risks associated with smoking, and the.
Pharmacotherapy for Smoking Cessation
Conclusions and Awards
Quick overview of quit smoking counseling for people with mental health or substance use disorders Associate Professor of.
Smoking Cessation Medication
TOBACCO AND SMOKING CESSATION
Anita R. Webb, PhD JPS Family Medicine Residency
screening, brief intervention, and referral to treatment
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing.
Tobacco Cessation Guidelines for COPD
Treating Tobacco Dependence
ABCs of Behavioral Support
Mini Lesson #1 – Smoking Cessation
The “Nuts and Bolts” of Tobacco Cessation in the Clinical Setting
Session #5 Medication.
Smoking cessation pt1 Mohammad AbuAssi.
Tobacco Cessation for Primary Care Providers
Presentation transcript:

Nicotine Addiction Pharmacy Practice II Winter 2005

Tobacco Use Interview When did you start? When did you start? Why? Why? How much, how often? How much, how often? What do you like? What do you like? What don’t you like? What don’t you like? Health risks? Health risks? Quitting experience? Quitting experience? What would it take to quit? What would it take to quit?

Pharmacist’s Role Ask Ask Advise Advise Assess Assess Assist Assist Arrange Arrange

Stages of Change Precontemplation Precontemplation Contemplation Contemplation Preparation Preparation Action Action Maintenance Maintenance

Precontemplation Unaware, unwilling, too discouraged Unaware, unwilling, too discouraged Won’t change in the next six months Won’t change in the next six months Listen, empathy, identify barriers Listen, empathy, identify barriers Focus on benefits of change Focus on benefits of change Interview questions Interview questions

Contemplation Open to information, thinking about quitting in next 6 months Open to information, thinking about quitting in next 6 months Provide information, emotional support Provide information, emotional support Encouragement Encouragement Resources Resources Information about options Information about options What it will take, who is available What it will take, who is available

Preparation Getting ready o try new behavior within 30 days Getting ready o try new behavior within 30 days Goal setting, praise readiness, enlist support of others Goal setting, praise readiness, enlist support of others Goals Goals Resources Resources Options Options Who can help Who can help

Action Taking steps, needing willpower Taking steps, needing willpower Habituating behaviors Habituating behaviors Stimulus control, reinforce + behaviors, continuing emotional support Stimulus control, reinforce + behaviors, continuing emotional support Action plans Action plans Other support Other support Product information Product information Positive effects Positive effects

Maintenance Engaged for at least six months Engaged for at least six months Continue emotional support Continue emotional support Relapse prevention Relapse prevention Reinforce benefits Reinforce benefits Relapse – encouragement, persistence Relapse – encouragement, persistence

Treatment options Behavior modification Behavior modification Nicotine lozenges Nicotine lozenges Nicotine gum Nicotine gum Nicotine patches Nicotine patches Nicotine inhaler Nicotine inhaler Nicotine nasal spray Nicotine nasal spray Bupropion SR Bupropion SR

Treatment options Nicotine polacrilex lozenges 2 mg (1 st cig > 30 min after waking) 2 mg (1 st cig > 30 min after waking) 4 mg (1 st cig < 30 min after waking) 4 mg (1 st cig < 30 min after waking) Allow to slowly dissolve (20-30 min) Allow to slowly dissolve (20-30 min) Do not chew, eat, or drink Do not chew, eat, or drink < 20 lozenges/d < 20 lozenges/d CI: pregnancy, CVD, PUD CI: pregnancy, CVD, PUD SE: hiccups, sore mouth, sore throat, nausea SE: hiccups, sore mouth, sore throat, nausea 12 weeks 12 weeks

Treatment options Nicotine polacrilex gum 2 mg ( 24 cigs/d) 2 mg ( 24 cigs/d) Bite and park Bite and park Avoid eating, drinking while chewing Avoid eating, drinking while chewing Acid decreases release Acid decreases release SE: hiccups, nausea, sore throat, sore mouth SE: hiccups, nausea, sore throat, sore mouth CI: pregnancy, CVD, esophagitis, PUD CI: pregnancy, CVD, esophagitis, PUD 12 weeks 12 weeks

Treatment Options Transdermal nicotine 7, 14, 21 mg, 24-hour 7, 14, 21 mg, 24-hour 5, 10, 15 mg, 16-hour 5, 10, 15 mg, 16-hour Usage guidelines p.1166 Usage guidelines p.1166 SE: local skin reaction, insomnia SE: local skin reaction, insomnia CI: pregnancy, CVD, derm. problems CI: pregnancy, CVD, derm. problems 8 weeks 8 weeks Must not use tobacco Must not use tobacco

Rx Nicotine replacement Nicotine Inhaler Nicotine Inhaler SE: local irritation of mouth & throat SE: local irritation of mouth & throat Up to 6 months Up to 6 months Nicotine Nasal Spray Nicotine Nasal Spray SE: nasal irritation SE: nasal irritation Up to 6 months Up to 6 months

Bupropion SR Wellbutrin, Zyban Wellbutrin, Zyban Antidepressant, dopamine reuptake inhibitor Antidepressant, dopamine reuptake inhibitor Start 1 week before quitting Start 1 week before quitting 150 mg q am x 3 d, then increase to bid (may take second dose mid afternoon) 150 mg q am x 3 d, then increase to bid (may take second dose mid afternoon) CI: History of seizure, eating disorders CI: History of seizure, eating disorders SE: insomnia, dry mouth SE: insomnia, dry mouth Can use with nicotine replacement Can use with nicotine replacement

What’s new? Rimonabant (Acomplia) Rimonabant (Acomplia) Cannabanoid Receptor Antagonist Cannabanoid Receptor Antagonist Weight loss, tobacco cessation Weight loss, tobacco cessation Phase III clinical trials Phase III clinical trials

Other considerations Costs Costs Irritability Irritability Weight gain Weight gain Proper disposal of products Proper disposal of products Abstinence rates Abstinence rates 14-30% vs 8-20% placebo 14-30% vs 8-20% placebo

References See Blackboard links See Blackboard links Treating Tobacco Use and Dependence, University of Wisconsin Medical School and center for Tobacco Research and Intervention Treating Tobacco Use and Dependence, University of Wisconsin Medical School and center for Tobacco Research and Intervention